The intestinal protozoan parasite Giardia lamblia is a major cause of persistent diarrhea in humans and animals worldwide. Treatment of giardiasis with nitro-prodrugs relies on intrinsic enzymes in G.lamblia that are involved in activating or deactivating the prodrugs. To elucidate more about the physiologic function of these pathways and their potential roles in drug resistance, G.lamblia wildtype and transgenic strains were metabolomically characterized based on 1H HR-MAS NMR data and specific metabolites that may be related to nitroreductase activity were identified and discussed.
This abstract and the presentation materials are available to members only; a login is required.